Nation on MSN1h
Why 58 per cent of people with HIV delay starting treatmentMore than half of people living with HIV in Kenya have delayed starting treatment because they fear their family members will discover their status. This is according to people living with HIV (PLHIV) ...
It took years of effort, but one new bill that passed the senate on Thursday will head to Governor Kelly Armstrong’s desk.
The Star on MSN5h
Revealed: List of HIV drugs remaining in KenyaHIV commodities worth about Sh30 billion are lying at the Mombasa Road warehouses of the Mission for Essential Drugs & Supplies (MEDS), awaiting distribution, the NSDCC has said.The consignment ...
8h
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
A partnership between communities and researchers is building health equity and including more underrepresented voices in ...
The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...
USAID was the pace-setter on locally led development," says Moses Isooba of the Uganda National NGO Forum. But now that it ...
Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback